Potentially lethal cardiac arrhythmias are a cardiovascular complication of severe aminophylline toxicity, i Despite the serious implications of these rhythm disturbances, little clinical and experimental information concerning the rational pharmacologic approach to this problem is available. Furthermore, much of the knowledge encompassing the medical management of arrhythmias was obtained from numerous experimental and clinical models which might not reproduce the electrical behaviour of the aminophylline toxic heart and thus are not totally applicable to this problem. 2 Moreover, the multiple cardiovascular and systemic effects of aminophylline secondary to phosphodiesterase inhibition, stimulation of catecholamine synthesis and release as well as altered intra-cellular calcium kinetics s can severely limit the usefulness of many antiarrhythmie agents.
Potentially lethal cardiac arrhythmias are a cardiovascular complication of severe aminophylline toxicity, i Despite the serious implications of these rhythm disturbances, little clinical and experimental information concerning the rational pharmacologic approach to this problem is available. Furthermore, much of the knowledge encompassing the medical management of arrhythmias was obtained from numerous experimental and clinical models which might not reproduce the electrical behaviour of the aminophylline toxic heart and thus are not totally applicable to this problem. 2 Moreover, the multiple cardiovascular and systemic effects of aminophylline secondary to phosphodiesterase inhibition, stimulation of catecholamine synthesis and release as well as altered intra-cellular calcium kinetics s can severely limit the usefulness of many antiarrhythmie agents.
In an effort to better understand these arrhythmias and to provide a more rational approach to their pharmacologic management, we independently investigated the calcium channel blocker verapamil and the beta adrenoreeeptor blocker propranolol in aminophylline toxic dogs.
Methods
Eighteen dogs were intubated and ventilated after induction of anaesthesia (pentobarbitone 30 mg/kg CAN ANAESTH sac J 1983 / 30:2 / pp 124-131
FIGURE 1 Summary of experimental model: As described in the method and summarized in Table I , repetitive aminophylline infusions (A) followed by phcnylephrine ((3) induced hypertension were continued until persistent veutricular arrhythmias resulted. Antiarrlayflmtir therapy (r'q) was then given, followed by a farther phenytephrine ehaltenge to establish whether the arrhythmias would recur. Graphic representation of electrocardiogram (ECG) and mean medal blood pressure (BP) are also shown.
and pancnronium 0.1 mg/kg). Supplemental pentobarbitone (2 mg/kg) was given qlh and as required. Electrocardiogram, arterial blood pressure and left ventricular end diastolic pressure were continuously monitored and recorded. Cardiac output and systemic vascular resistance were computed by thermodilution technique using a Swan Ganz catheter. A separate right atrial catheter was placed for cold saline injection. Serum electrolytes including ,~-alcium, arterial blood gas tensions pH and serial auunophylline levels were measured. All animals were rendered toxic by arninophylline infusion, an initial dose of 50mg/kg over five minutes with subsequent doses of 10 mg/kg over 30 seconds. Twenty minutes after each aminophylline infusion the dog was challenged with phenylephfine (10-201xg/kg). This resulted in short duration hypertension, and reproducible emergence of ventricular arrhythmias when a toxic aminophylline level was reached. The dogs continued to receive additional aminophyiline infusions followed by subsequent phenylephrine challenge until these arrhythmias persisted over a 120-second observation period (Fig. 1 ). Arrhythmias were defined as frequent ventrieular ectopics, ventricular tachycar- Ventrlcular ectopics were defined by the presence of at least three of the following criteria: (1) the QRS complex was different than a sinus conducted impulse; (2) no evidence of rate-related aberrant conduction; (3) QRS duration was greater than 120 msec; (4) presence of occasional fusion beats; (5) presence of a full compensatory pause. Criteria for ventricular tachycardia included: (1) QRS duration of greater than 120 msec; (2) QRS complex different from a sinus conducted pulse; (3) no evidence of rate-related aberrancy with atrial rates faster than the defined arrhythmias; (4) presence of fusion and capture beats; (5) presence of complete atrioventricular dissociation.
Although data were continuously recorded, pre, during and post specific event points were chosen for analysis (Table I) . Analysis of data was by paired t-test, p < 0.05 was considered significant. All values are recorded as mean -+ standard deviation.
All arrhythmias were confirmed by a cardiologist who was not informed of the experimental group at the time of evaluation.
Results
All dogs in Group I died of ventricular arrhythmias when the serum aminophylline level reached 153 -+ 23.31xg/ml (Fig. 2) . There was no significant difference between the serum aminophylline levels at the time of persistent ventricular arrhythmia in all three groups (Table II) . Analysis of biochemical, blood gas tensions and pH data showed no significant difference between the three groups ( Table m) . The haemodynamic, chronotropic and electrophysiologic effects of aminophylline are summarized in Table IV (columns A and C). These results are similar to those reported by others.'* In Group II these arrhythmias were promptly terminated by verapamil in all six dogs (mean time 99 -+ 47.8 seconds). As summarized in Table IV (column B) and Figure 3 , verapamil resulted in a 33.3 per cent decrease in arterial blood pressure while systemic vascular resistance fell 41.4 per cent. Transient second degree atrioventficular block (mean time 52 seconds) and subsequent PR interval prolongation were also noted. Repeat phenylephrine challenge did not re-institute these arrhythmias in any dog in this group (Table V) .
In Group III propranolol resulted in rapid (mean time 83 + 77 seconds) but partial arrhythmia control, three dogs requiring additional doses of propranolol. Significant changes observed with the administration of propranolol included heart rate slowing, prolongation of the PR interval and a decrease in cardiac index (Table IV ( (Table V) .
Discussion
This study demonstrated that verapamil and propranolol in therapeutic doses were effective antiarrhythmics in aminophyUine toxic dogs. Our observations differ slightly from previously published information, 3'5 in that our animals required consistently higher serum aminophylline levels to develop arrhythmias. Despite this, the serum levels of aminophylline seen in our study are not different from those reported from clinical experience, t Furthermore, these high levels of aminophylline did not seem to alter the antiarrhythmic properties of verapamil or pmpranolol, Analysis of antiarrhythmic efficacy by simple arrhythmia control in aminophylline toxic dogs has severe inherent limitations since previous researchers a have demonstrated that these arrhythmias are often short-lived and self-terminating. This elecIrophysiologie behaviout clearly precludes simple arrhythmia control as an effective therapeutic endpoint, since terminating a seemingly stable arrhythmia after the administration of any given drug could be a coincidence which might not necessarily reflect antiarrhythmic effectiveness. For these reasons we had to create a reliable and reproducible manoeuvre, capable of consistently triggering ventrieular anhythmias. Acute blood pressure elevation by intra-aortic balloon inflation or incremental boluses of phenylephrine always resulted in the emergence of ventricular arrhythmias in aminophylline toxic dogs. Since both hypertensive manoeuvres were effective in generating ventricular arrhythmias we elected the latter, for practical reasons. Although it has been demonstrated that phenylephrine can produce an increase in myocardial cyclic AMP in vitro, this effect has not been shown in the intact 6 animal. Therefore we do not think that the arrhythmias precipitated by this presser agent were secondary to its cellular effects. In this context, acute intra-ao:rtic balloon inflation, a manoeuvre devoid of similar cellular effects, was also effective in consistently eliciting ventricular arrhythmias in the aminophylline toxic dog. These observations were in sharp contrast to previous studies demonstrating that an acute blood pressure elevation has a protective effect against ventricular arrhythmias in the dog. 7 Although we did not include a His bundle recording for the documentation of these arrhythmias the criteria previously described provided strong evidence in favour of a ventricular origin. Moreover these arrhythmias proved to be lethal in the untreated control group.
Unfortunately the cellular mechanisms underlying aminophylline-induced arrhythmias remain only partially understood. Our observations do not allow us to establish whether this electrophysiologic bchaviour is secondary to abnormal automaticity, re-entry or oscillatory after-potentials. This study did demonstrate that sudden myocardial and Table I. purkinje fiber stretch, accomplished by sudden hypertension, played a crucial role in the initiation of these alrhythmias. 8 In addition, these observations showed the crucial interaction between the mechanical and electrical behaviour of the heart, but more importantly highlighted the potential deleterious effects of pressor agents in the treatment of hypotension secondary to aminophylline toxicity. Verapamil, apart from its central cardiac effects, is a potent peripheral vasodilator.9 The antiarrhythmie properties demonstrated were independent of its effects on blood pressure and systemic vascular resistance since subsequent pressure challenges to arrhythmogenic pre-verapamil levels were ineffective in re-instituting these ventricular arrhythrnias. An antiarrhythmic effect secondary to a drop in blood pressure was further excluded by producing profound hypotension induced by operting an arteriovenous shunt without observing rhythm conversion (unpublished data). Furthermore, during stable ventricular tachycardia some of the animals showed profound and persistent hypotension which not only did not result in spontaneous conversion, but if left untreated always degenerated into terminal ventricular fibrillation (Group I).
Propranolol appeared a less effective antiarrhythmic than verapamil since it did not completely suppress the arrhythmias in three dogs and could not prevent the re-emergence of ventricular ectopics in four following a repeat phenylephrine challenge (Table V) .
Although verapamil had more statistically and clinically significant adverse effects than propranolol they were short-lived and self-terminating. Other investigators have suggested that the hypotension associated with intravenous verapamil administration is related to the rate of administration. to Therefore, it is conceivable that the profound haemodynamic changes seen with the administration of verapamil in this study were related to administration rate. Verapamil was a more effective antiarrhythmic than propranolol in the aminophylline toxic dog model as described above. Perhaps more importantly it should be realized that propranoloi therapy is a relative contraindication for those with asthma, a condition commonly treated with aminophylline.
Despite the effectiveness of these anliarrhythmics in the presence of high amlnophylline levels as described in this animal model, it is difficult to predict their usefulness in aminophylline toxic patients.
Finally the predictable nature and ease of induction of these aggressive ventricular arrhythmias, highlights the potential usefulness of this animal model for the study of many other electrophysiologic problems.
